Product introduction:
Vologlipide is an oral hypoglycemic agent that can improve postprandial hyperglycemia in diabetics. α- Glucosidase inhibitor (a drug that can slow down the absorption of carbohydrates in the intestine and achieve hypoglycemic effect), the mechanism of action is to inhibit the disaccharide hydrolase that decomposes disaccharides into monosaccharides in the intestine( α- Glucosidase), thus delaying the digestion and absorption of sugar, so as to improve postprandial hyperglycemia.
CAS:83480-29-9
Molecular formula: C10H21NO7
Molecular weight: 267.28
Structural type:
Usage: Diabetes remedy